In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Disipal Drug Master File in Korea (Disipal KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Disipal. The MFDS reviews the Disipal KDMF as part of the drug registration process and uses the information provided in the Disipal KDMF to evaluate the safety and efficacy of the drug.
After submitting a Disipal KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Disipal API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Disipal suppliers with KDMF on PharmaCompass.